+919405117673

Mounjaro® (Tirzepatide) Injection is a prescription medicine used for type 2 diabetes management and, in approved markets, weight management in eligible adults. Cordium Pharmaceuticals Pvt Ltd supports international pharmaceutical supply enquiries for eligible hospitals, pharmacies, pharmaceutical distributors and importers.

We coordinate pharmaceutical supply enquiries for Washington, New York, California, Dubai, Abu Dhabi, London, Manchester, Birmingham, Johannesburg, Cape Town and Durban, subject to local prescription, import and regulatory requirements.

Mounjaro® (Tirzepatide) Injection

Mounjaro® contains tirzepatide, a dual GIP and GLP-1 receptor agonist. It helps improve blood-glucose control and can support weight management when prescribed alongside appropriate diet and physical activity.

Available Strengths

Depending on market availability, Mounjaro® presentations include:

2.5 mg | 5 mg | 7.5 mg | 10 mg | 12.5 mg | 15 mg

Mounjaro® is administered once weekly, with the appropriate dose determined by a qualified healthcare professional.

Fast Pharmaceutical Supply

Cordium Pharmaceuticals Pvt Ltd provides international supply coordination for eligible pharmaceutical buyers seeking Mounjaro® and tirzepatide products.

Service locations include:

  • USA: Washington, New York & California
  • UAE: Dubai & Abu Dhabi
  • UK: London, Manchester & Birmingham
  • South Africa: Johannesburg, Cape Town & Durban

Delivery timelines depend on destination, customs clearance, documentation and applicable import regulations. We do not guarantee a specific delivery time until an order and shipping route are confirmed.

Mounjaro® for Diabetes & Weight Management

Tirzepatide may be prescribed for:

  • Type 2 diabetes management
  • Blood-glucose control
  • Weight management in eligible adults
  • Supporting weight reduction alongside lifestyle measures

Mounjaro® should only be used according to a healthcare professional's prescription and the approved indication in the destination country.

Why Choose Cordium Pharma?

Cordium Pharmaceuticals Pvt Ltd provides professional pharmaceutical export support from India.

Key Benefits

  • India-based pharmaceutical exporter
  • International supply coordination
  • Support for hospitals and pharmaceutical distributors
  • Professional order processing
  • Export documentation assistance
  • International shipping coordination
  • Support for eligible import requirements
  • Destination-specific logistics support

Frequently Asked Questions

1. What is Mounjaro® Injection?

Mounjaro® is a prescription medicine containing tirzepatide, used for type 2 diabetes and, in certain markets, weight management.

2. What strengths of Mounjaro® are available?

Common strengths include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg, subject to market availability.

3. How often is Mounjaro® administered?

Mounjaro® is generally administered once weekly. Dose selection and escalation should be determined by a healthcare professional.

4. Can Cordium Pharmaceuticals supply Mounjaro® internationally?

Cordium Pharmaceuticals Pvt Ltd handles international pharmaceutical supply enquiries for eligible buyers, subject to product availability and the regulations of the destination country.

5. Do you provide supply to Dubai, London, New York and other listed cities?

Yes, Cordium Pharmaceuticals can coordinate eligible pharmaceutical supply enquiries for customers in Washington, New York, California, Dubai, Abu Dhabi, London, Manchester, Birmingham, Johannesburg, Cape Town and Durban, subject to local import requirements.

6. Is Mounjaro® available without a prescription?

Mounjaro® is a prescription medicine. Buyers should follow the prescription, dispensing and import regulations applicable in their country.

Conclusion

For Mounjaro® (Tirzepatide) Injection supply from India, Cordium Pharmaceuticals Pvt Ltd supports eligible pharmaceutical buyers across the USA, UAE, UK and South Africa. Contact Cordium Pharma for product availability, quotation, documentation and shipping information.

Aug 18th, 2026 3:06 PM